| 摘要 |
The present invention relates to a new therapeutic composition useful for magnesic deficiencies to enterically release the magnesium contained therein in a slow and continuous way, said composition being characterized in that it is comprised of a mixture containing, in association with a physiologically acceptable vehicle, (A) from 4 to 14 parts by weight of magnesium from a magnesium source comprised of MgO, MgCl2 and the magnesium chloride hydrates having the formula MgCl2, nH2O where n is an integer or fractional number higher than 0 and not exceeding 6, and (B) from 6 to 13 parts by weight of a hydrophilic polymer, when the source of Mg is MgO, or from 10 to 30 parts by weight of a hydrophobic substance selected amongst the group including the physiologically acceptable hydrophobic polymers, the fatty acid esters and mixtures thereof, when the source Mg is different from MgO, the Mg content in said mixture being between 5 and 60 % by weight based on the weight of said mixture. |
